Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Menopause
Biotech
Bayer posts pivotal data on rival to Astellas in menopause space
The phase 3 data suggest Bayer could challenge Astellas for a recently unlocked menopause market.
Nick Paul Taylor
May 17, 2024 6:45am
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Mar 19, 2024 7:17am
Biden asks Congress for $12B to fund women's health research
Mar 8, 2024 10:25am
Bayer hits hot flash phase 3 goals to stay on Astellas’ heels
Jan 8, 2024 10:16am
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Mar 17, 2023 10:11am
FDA thwarts Astellas' accelerated approval ambition in menopause
Feb 20, 2023 7:20am
